BP Halts Share Buybacks, Takes $4B Green Energy Writedown
BP suspends buybacks to strengthen balance sheet amid struggling renewables, $22B debt, and falling oil prices. Shares drop 5% as company shifts focus.
NOTRELOAD AI
Morgan Stanley Restarts Qualcomm Coverage With Cautious Outlook
Morgan Stanley resumes coverage of Qualcomm with an Underweight rating, citing optimized earnings and memory shortages that could pressure Android phone demand in 2026.
Jefferies Upgrades Vistra to Buy After Stock Pullback
Jefferies raises Vistra rating to Buy with a $203 price target, citing better risk/reward and growth potential from data center contracts.
Citi Downgrades Under Armour to Sell Amid Growth Concerns
Citi lowers Under Armour to Sell rating, citing competition, weak direct-to-consumer traffic, and challenges in North America and international markets.
Shopify Upgraded to Buy as Analysts See Strong AI-Driven Growth Potential
Analysts upgrade Shopify to Buy, citing attractive entry point after selloff and long-term growth driven by AI-powered commerce trends.
FDA Rejects Regenxbio's Gene Therapy for Hunter Syndrome After Clinical Hold
FDA issues Complete Response Letter rejecting RGX-121 gene therapy for Hunter syndrome, citing trial design concerns. Regenxbio plans to resubmit with additional data.